Common Contracts

AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales Agreement

Capital on Demand Sales Agreement • May 20th, 2022 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Capital on Demand Sales Agreement
• Filed
  May 20th, 2022
• Company
  Aeglea BioTherapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through or to JonesTrading Institutional Services LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), on the terms set forth in this agreement (this “Agreement”).

AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales Agreement

Capital on Demand Sales Agreement • April 16th, 2020 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Capital on Demand Sales Agreement
• Filed
  April 16th, 2020
• Company
  Aeglea BioTherapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through or to JonesTrading Institutional Services LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), on the terms set forth in this agreement (this “Agreement”).